Preferred Name |
Tolbutamide |
|
Synonyms |
|
|
Definitions |
A short-acting, first-generation sulfonylurea with hypoglycemic activity. Compared to second-generation sulfonylureas, tolbutamide is more likely to cause adverse effects, such as jaundice. This agent is rapidly metabolized by CYPC29. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C66610 |
|
CAS_Registry |
64-77-7 |
|
CHEBI_ID |
CHEBI:27999 |
|
Chemical_Formula |
C12H18N2O3S |
|
code |
C66610 |
|
Contributing_Source |
CTRP FDA |
|
definition |
A short-acting, first-generation sulfonylurea with hypoglycemic activity. Compared to second-generation sulfonylureas, tolbutamide is more likely to cause adverse effects, such as jaundice. This agent is rapidly metabolized by CYPC29. |
|
Display_Name |
Tolbutamide |
|
FDA_UNII_Code |
982XCM1FOI |
|
Has_Salt_Form | ||
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C176424 |
|
label |
Tolbutamide |
|
Legacy Concept Name |
Tolbutamide |
|
NCI_Drug_Dictionary_ID |
684270 |
|
PDQ_Closed_Trial_Search_ID |
684270 |
|
PDQ_Open_Trial_Search_ID |
684270 |
|
Preferred_Name |
Tolbutamide |
|
prefixIRI |
NCIT:C66610 |
|
prefLabel |
Tolbutamide |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0040374 |
|
subClassOf |